- Recommendation ID
- NG206/02
- Question
A core outcome set: What core set of relevant health outcome measures should be used for trials of treatments for ME/CFS and managing symptoms of ME/CFS?
- Any explanatory notes
(if applicable) For a short explanation of why the committee made this recommendation, see the rationale section on managing ME/CFS. Full details of the evidence and the committee's discussion are in evidence review G: nonpharmacological management of ME/CFS.
Source guidance details
- Comes from guidance
- Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management
- Number
- NG206
- Date issued
- October 2021
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 31/10/2021 |